HomeCompareRAONF vs PLD

RAONF vs PLD: Dividend Comparison 2026

RAONF yields 76.92% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $4.46M in total portfolio value· pulled ahead in Year 9
10 years
RAONF
RAONF
● Live price
76.92%
Share price
$2.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.45M
Annual income
$406,212.55
Full RAONF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — RAONF vs PLD

📍 PLD pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRAONFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RAONF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RAONF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RAONF
Annual income on $10K today (after 15% tax)
$6,538.46/yr
After 10yr DRIP, annual income (after tax)
$345,280.67/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $3,692,835.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RAONF + PLD for your $10,000?

RAONF: 50%PLD: 50%
100% PLD50/50100% RAONF
Portfolio after 10yr
$3.68M
Annual income
$2,578,468.86/yr
Blended yield
70.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

RAONF
No analyst data
Altman Z
259.5
Piotroski
2/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RAONF buys
0
PLD buys
0
No recent congressional trades found for RAONF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRAONFPLD
Forward yield76.92%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$1.45M$5.91M
Annual income after 10y$406,212.55$4,750,725.19
Total dividends collected$1.25M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: RAONF vs PLD ($10,000, DRIP)

YearRAONF PortfolioRAONF Income/yrPLD PortfolioPLD Income/yrGap
1$18,392$7,692.31$11,241$540.96+$7.2KRAONF
2$32,902$13,222.36$13,019$991.13+$19.9KRAONF
3$57,311$22,106.15$15,801$1,870.97+$41.5KRAONF
4$97,310$35,987.08$20,609$3,701.21+$76.7KRAONF
5$161,228$57,105.82$29,919$7,867.97+$131.3KRAONF
6$260,939$88,425.56$50,631$18,617.74+$210.3KRAONF
7$412,955$133,749.94$105,528$51,352.20+$307.4KRAONF
8$639,683$197,821.28$287,364$174,449.42+$352.3KRAONF
9← crossover$970,847$286,385.73$1,081,760$774,280.77$110.9KPLD
10$1,445,019$406,212.55$5,908,209$4,750,725.19$4.46MPLD

RAONF vs PLD: Complete Analysis 2026

RAONFStock

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.

Full RAONF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this RAONF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RAONF vs SCHDRAONF vs JEPIRAONF vs ORAONF vs KORAONF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.